Fujian Tianma Science and Technology Group Co., Ltd
SSE:603668.SS
12.95 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,854.13 | 6,997.725 | 7,007.53 | 5,419.022 | 3,639.957 | 2,428.384 | 1,506.181 | 1,136.35 | 843.663 | 808.605 | 699.395 | 550.627 | 650.068 | 448.253 |
| Cost of Revenue
| 5,218.523 | 6,472.176 | 6,336.191 | 4,865.595 | 3,233.003 | 2,119.412 | 1,243.522 | 906.734 | 657.13 | 648.886 | 554.465 | 428.615 | 531.663 | 368.188 |
| Gross Profit
| 635.607 | 525.549 | 671.34 | 553.427 | 406.954 | 308.972 | 262.659 | 229.616 | 186.533 | 159.719 | 144.93 | 122.012 | 118.405 | 80.064 |
| Gross Profit Ratio
| 0.109 | 0.075 | 0.096 | 0.102 | 0.112 | 0.127 | 0.174 | 0.202 | 0.221 | 0.198 | 0.207 | 0.222 | 0.182 | 0.179 |
| Reseach & Development Expenses
| 114.175 | 129.54 | 126.067 | 99.636 | 85.705 | 67.615 | 55.949 | 37.144 | 32.315 | 27.115 | 24.95 | 22.276 | 17.543 | 0 |
| General & Administrative Expenses
| 40.584 | 46.523 | 38.464 | 31.577 | 18.61 | 20.752 | 8.785 | 14.998 | 7.442 | 6.232 | 7.43 | 10.527 | 38.765 | 32.446 |
| Selling & Marketing Expenses
| 13.586 | 90.808 | 68.17 | 65.852 | 54.954 | 51.528 | 41.937 | 36.252 | 27.403 | 22.257 | 19.949 | 14.938 | 16.957 | 9.152 |
| SG&A
| 54.17 | 110.163 | 106.635 | 97.429 | 73.563 | 72.28 | 50.722 | 51.25 | 34.845 | 28.488 | 27.378 | 25.465 | 55.722 | 41.598 |
| Other Expenses
| 408.951 | 412.803 | 125.712 | 102.944 | 75.262 | 48.182 | 0.284 | 2.81 | 8.881 | 11.986 | 4.072 | 5.686 | -0.992 | -0.043 |
| Operating Expenses
| 577.297 | 677.652 | 358.415 | 300.01 | 234.53 | 188.077 | 133.129 | 104.705 | 85.29 | 71.154 | 66.263 | 60.118 | 55.84 | 41.625 |
| Operating Income
| 58.31 | -147.002 | 296.15 | 233.977 | 127.018 | 85.584 | 84.574 | 103.548 | 84.125 | 64.734 | 65.901 | 49.523 | 55.826 | 31.615 |
| Operating Income Ratio
| 0.01 | -0.021 | 0.042 | 0.043 | 0.035 | 0.035 | 0.056 | 0.091 | 0.1 | 0.08 | 0.094 | 0.09 | 0.086 | 0.071 |
| Total Other Income Expenses Net
| -2.333 | -18.823 | -90.865 | -52.824 | 7.624 | -8.198 | -27.601 | 2.81 | -6.416 | -9.066 | -6.588 | 5.631 | -9.858 | -0.043 |
| Income Before Tax
| 55.978 | -165.826 | 194.11 | 158.643 | 126.642 | 84.841 | 84.858 | 106.358 | 92.997 | 76.705 | 69.955 | 55.154 | 54.456 | 31.573 |
| Income Before Tax Ratio
| 0.01 | -0.024 | 0.028 | 0.029 | 0.035 | 0.035 | 0.056 | 0.094 | 0.11 | 0.095 | 0.1 | 0.1 | 0.084 | 0.07 |
| Income Tax Expense
| 7.704 | -11.157 | 19.431 | 26.841 | 18.13 | 8.974 | 11.225 | 15.823 | 12.926 | 10.842 | 10.663 | 7.971 | 8.27 | 5.022 |
| Net Income
| 26.033 | -187.554 | 174.679 | 131.801 | 108.511 | 75.868 | 73.547 | 90.86 | 80.293 | 66.047 | 59.544 | 47.317 | 41.573 | 23.726 |
| Net Income Ratio
| 0.004 | -0.027 | 0.025 | 0.024 | 0.03 | 0.031 | 0.049 | 0.08 | 0.095 | 0.082 | 0.085 | 0.086 | 0.064 | 0.053 |
| EPS
| 0.05 | -0.39 | 0.4 | 0.35 | 0.33 | 0.24 | 0.25 | 0.31 | 0.36 | 0.3 | 0.26 | 0.22 | 0.24 | 0.29 |
| EPS Diluted
| 0.05 | -0.39 | 0.4 | 0.35 | 0.33 | 0.24 | 0.25 | 0.31 | 0.36 | 0.3 | 0.26 | 0.22 | 0.24 | 0.29 |
| EBITDA
| 486.769 | 212.848 | 438.575 | 308.717 | 229.717 | 138.31 | 143.743 | 148.264 | 123.117 | 96.269 | 85.711 | 74.453 | 69.34 | 42.687 |
| EBITDA Ratio
| 0.083 | 0.03 | 0.063 | 0.057 | 0.063 | 0.057 | 0.095 | 0.13 | 0.146 | 0.119 | 0.123 | 0.135 | 0.107 | 0.095 |